Cold Chain Technologies (CCT), a global provider of temperature-controlled packaging products and services in collaboration with industry resource firm CoolPack.com released an industry-wide survey intended to benchmark the methods used to maintain the efficacy of temperature-sensitive therapeutics throughout the supply chain.
“The biopharmaceutical industry is in need of value-added insight into navigating a rapidly changing landscape. This survey aims to shed light on a global scale with the intent of delivering useful and applicable results,” says TJ Rizzo, Senior Vice President of Global Commercial Operations at Cold Chain Technologies.
Ongoing mergers and acquisitions, organizational restructuring and shifts in organization focus has led to many questions about the structure of packaging and engineering functions.
Ben Romero, President of CoolPack, says, “We are excited to participate in this survey, which we believe will provide valuable insight to biopharma cold chain and packaging professionals, and we look forward to sharing the results with our audience.”
The survey will run from July, 25 2016 until Sept. 30, 2016, with results to be shared in Oct. 2016 directly to respondents and publicly via a formal report that will also become available on www.coldchaintech.com and www.coolpack.com.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
